Inventiva (France) Today
| IVA Stock | EUR 2.99 0.17 5.38% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Inventiva is trading at 2.99 as of the 5th of May 2024, a -5.38 percent decrease since the beginning of the trading day. The stock's open price was 3.16. Inventiva has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Inventiva SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of May 2022 and ending today, the 5th of May 2024. Click here to learn more.
Inventiva S.A., a biopharmaceutical company, develops drugs for the treatment of fibrotic, cancer, and orphan diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. INVENTIVA is traded on Paris Stock Exchange in France. The company has 42.13 M outstanding shares. More on Inventiva SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Inventiva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Inventiva's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Inventiva or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Inventiva SA (IVA) is traded on Euronext Paris in France and employs 109 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 214.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inventiva's market, we take the total number of its shares issued and multiply it by Inventiva's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Inventiva SA operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 42.13 M outstanding shares.
Inventiva SA has accumulated about 56.69 M in cash with (47.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.54.
Check Inventiva Probability Of Bankruptcy
Ownership AllocationInventiva secures a total of 42.13 Million outstanding shares. Inventiva secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Inventiva Ownership Details
Inventiva Stock Price Odds Analysis
What are Inventiva's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Inventiva jumping above the current price in 90 days from now is under 95%. The Inventiva SA probability density function shows the probability of Inventiva stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.4509. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inventiva will likely underperform. Additionally, inventiva SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Inventiva to move above the current price in 90 days from now is under 95 (This Inventiva SA probability density function shows the probability of Inventiva Stock to fall within a particular range of prices over 90 days) .
Inventiva SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Inventiva market risk premium is the additional return an investor will receive from holding Inventiva long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Inventiva. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Inventiva's alpha and beta are two of the key measurements used to evaluate Inventiva's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.43 | |||
| Standard Deviation | 3.66 | |||
| Variance | 13.42 | |||
| Risk Adjusted Performance | (0.02) |
Inventiva Stock Against Markets
Picking the right benchmark for Inventiva stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Inventiva stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Inventiva is critical whether you are bullish or bearish towards Inventiva SA at a given time. Please also check how Inventiva's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Inventiva without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Inventiva Corporate Management
Elected by the shareholders, the Inventiva's board of directors comprises two types of representatives: Inventiva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inventiva. The board's role is to monitor Inventiva's management team and ensure that shareholders' interests are well served. Inventiva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inventiva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jean Volatier | Chief Officer | Profile | |
| Eric LLM | G Counsel | Profile | |
| Frederic Cren | CEO CoFounder | Profile | |
| JeanPaul MD | Head Pharmacovigilance | Profile | |
| Michael Cooreman | Chief Officer | Profile | |
| Pierre Broqua | Chief CoFounder | Profile | |
| Irena Konstantinova | Head Pharmacology | Profile |
How to buy Inventiva Stock?
Before investing in Inventiva, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Inventiva. To buy Inventiva stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Inventiva. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Inventiva stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Inventiva SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Inventiva SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Inventiva SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Inventiva Stock please use our How to Invest in Inventiva guide.
Already Invested in Inventiva SA?
The danger of trading Inventiva SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Inventiva is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Inventiva. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Inventiva SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inventiva SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Inventiva SA information on this page should be used as a complementary analysis to other Inventiva's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Inventiva Stock analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |